MAVACAMTEN: A door that has opened in the treatment of Hypertrophic Cardiomyopathy

被引：1
|
作者：
Hameed, Ishaque [1 ]
Siddiqui, Omer Mustafa [1 ]
Samad, Syed Abdus [2 ]
机构：
[1] Dow Univ Hlth & Sci, Civil Hosp, Dept Internal Med, Karachi, Pakistan
[2] Dow Univ Hlth & Sci, Civil Hosp, Dept Gen Surg, Karachi, Pakistan
来源：
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2023年 / 73卷 / 02期
关键词：
D O I：
10.47391/JPMA.7258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：446 / 447
页数：2
相关论文
共 50 条
  • [41] LONG-TERM COST EFFECTIVENESS OF MAVACAMTEN FOR TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM)
    Sarker, J.
    Joshi, M.
    Wasfy, J. H.
    Beinfeld, M.
    Nhan, E.
    Whittington, M.
    Pearson, S. D.
    Rind, D. M.
    Walton, S. M.
    VALUE IN HEALTH, 2022, 25 (07) : S424 - S424
  • [42] The Effect of Mavacamten Treatment on Hemolysis Biomarkers in Patients With Obstructive Hypertrophic Cardiomyopathy in the EXPLORERHCM Study
    Wang, Zhaoqing
    Anderson, Warren
    Sehnert, Amy J.
    He, Aiqing
    Kurio, Gregory
    Olivotto, Iacopo
    Schafer, Peter
    CIRCULATION, 2023, 148
  • [43] Chronic Mavacamten Treatment Has Opposing Effects on Contractility in Engineered Heart Tissue Models of Severe vs. Mild Hypertrophic Cardiomyopathy
    De Lange, Willem J.
    Gauchan, Angeela
    Nelson, Natalie A.
    Farrell, Emily T.
    Ralphe, John C.
    CIRCULATION, 2023, 148
  • [44] A Systematic Review and Meta-analysis of Efficacy and Safety of Mavacamten for the Treatment of Hypertrophic Cardiomyopathy
    Zheng, Li
    Gu, Xiaotong
    Chen, Yumiao
    Liu, Deping
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (10)
  • [45] Outcomes of a Multidisciplinary Approach to Management of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
    Willeford, Andrew
    Huynh, Trina
    Kraushaar, Megan
    Enciso, Jorge Silva
    CIRCULATION, 2023, 148
  • [46] Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction
    Desai, Milind Y.
    Owens, Anjali
    Wolski, Kathy
    Geske, Jeffrey B.
    Saberi, Sara
    Wang, Andrew
    Sherrid, Mark
    Cremer, Paul C.
    Lakdawala, Neal K.
    Tower-Rader, Albree
    Fermin, David
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Zhong, Yue
    Wyrwich, Kathleen W.
    Lampl, Kathy L.
    Sehnert, Amy J.
    Nissen, Steven E.
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (11) : 1041 - 1045
  • [47] Comparison of Alcohol Septal Ablation With Mavacamten in Obstructive Hypertrophic Cardiomyopathy
    Samhan, Ashraf
    Saleh, Danish
    Kim, Ellis Y.
    Hu, Mo
    Mueller, Kayla
    Garza, Abigail
    Schormann, Elizabeth
    Bindra, Parmeen
    Cheema, Baljash
    Fullenkamp, Dominic E.
    Baldridge, Abigail S.
    Puthumana, Jyothy J.
    Flaherty, James D.
    Choudhury, Lubna
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 239 : 51 - 56
  • [48] Comparison of Alcohol Septal Ablation with Mavacamten in Obstructive Hypertrophic Cardiomyopathy
    Samhan, Ashraf
    Saleh, Danish
    Kim, Ellis
    Hu, Mo
    Mueller, Kayla
    Garza, Abigail
    Baldridge, Abigail
    Puthumana, Jyothy
    Flaherty, James
    Choudhury, Lubna
    CIRCULATION, 2024, 150
  • [49] Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy
    Garcia-Pavia, Pablo
    Oreziak, Artur
    Masri, Ahmad
    Barriales-Villa, Roberto
    Abraham, Theodore P.
    Owens, Anjali T.
    Jensen, Morten K.
    Wojakowski, Wojciech
    Seidler, Tim
    Hagege, Albert
    Lakdawala, Neal K.
    Wang, Andrew
    Wheeler, Matthew T.
    Choudhury, Lubna
    Balaratnam, Ganesh
    Shah, Ashish
    Fox, Shawna
    Hegde, Sheila M.
    Olivotto, Iacopo
    EUROPEAN HEART JOURNAL, 2024,
  • [50] Mavacamten, an Alternative to Septal Reduction Therapy for Patients with Hypertrophic Cardiomyopathy
    Desai, Milind Y.
    Ali, Adel Hajj
    HEART INTERNATIONAL, 2023, 17 (01): : 2 - 4
12345